ZYDUSWELL
ZYDUS WELLNESS LIMITED
Each stock's 10,000-path forecast, rendered as light.
ZYDUS WELLNESS LIMITED (ZYDUSWELL) Stock Analysis & Case Study
Is ZYDUSWELL a good buy? The data-driven verdict.
ZYDUS WELLNESS LIMITED (ZYDUSWELL) trades at ₹530,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, ZYDUS WELLNESS LIMITED (ZYDUSWELL) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 76.3× earnings, ROE of 4.0%, a 56% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
ZYDUSWELL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How ZYDUSWELL ranks against the 2,373 companies in our screener
- ZYDUSWELL's market cap of 16,985 Cr ranks in the 83rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ZYDUSWELL's book value of ₹183 ranks in the 69th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ZYDUSWELL's promoter holding of 69.6% ranks in the 73rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ZYDUSWELL's 3-year profit (PAT) growth of -10.0% ranks in the 19th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ZYDUSWELL's 3-year revenue growth of 21.0% ranks in the 75th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ZYDUSWELL's debt-to-equity ratio of 0.55x is lower than 32% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is ZYDUSWELL overvalued? ZYDUSWELL P/E vs peers
ZYDUSWELL trades at 76.3× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
ZYDUSWELL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of ZYDUSWELL history (12%/yr drift, 34%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ZYDUSWELL 2027 | ₹362 | ₹564 | ₹880 | +6% |
| ZYDUSWELL 2028 | ₹318 | ₹596 | ₹1,116 | +12% |
| ZYDUSWELL 2029 | ₹291 | ₹629 | ₹1,359 | +18% |
| ZYDUSWELL 2030 | ₹275 | ₹665 | ₹1,605 | +25% |
| ZYDUSWELL 2031 | ₹265 | ₹702 | ₹1,860 | +32% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ZYDUSWELL goes up, or doubles?
The bull case for ZYDUSWELL
- ZYDUS WELLNESS LIMITED is part of the nifty200 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,359.
The bear case & risks
- ZYDUSWELL's P/E of 76.7x is lower than 15% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ZYDUSWELL's return on equity of 4.0% ranks in the 26th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹291.
ZYDUSWELL volatility & expected range, how bumpy is the ride?
Over the last 9.8 years ZYDUSWELL compounded at 12%/year with annualized volatility of 34%. That volatility implies a 1-year 80% range of ₹362-₹880, the honest backbone behind any single price target.
ZYDUSWELL price forecast, the full 60-month probability fan
ZYDUSWELL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ZYDUSWELL hits common targets within the simulated horizon?
Full multi-horizon detail on the ZYDUSWELL price target & forecast page.
ZYDUSWELL Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. ZYDUSWELL scores 5/8, mixed financial health.
ZYDUSWELL MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy ZYDUSWELL with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 32.61% | 3.1× |
| Zerodha | 32.57% | 3.1× |
| Groww | 32.65% | 3.1× |
| Dhan | 32.57% | 3.1× |
| Kotak Neo | 32.57% | 3.1× |
| Paytm Money | 32.65% | 3.1× |
| PocketfulCHEAPEST | 32.37% | 3.1× |
| Anand Rathi | 32.57% | 3.1× |
| Bajaj Broking | 33.00% | 3.0× |
| Share India | 32.61% | 3.1× |
Compare every broker on the ZYDUSWELL MTF page.
About ZYDUS WELLNESS LIMITED: sector, index & market-cap context
ZYDUS WELLNESS LIMITED (ZYDUSWELL) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹16,908 Cr. See more stocks on our screener.
How the ZYDUSWELL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of ZYDUS WELLNESS LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ZYDUSWELL analysis, FAQs
Is ZYDUS WELLNESS LIMITED (ZYDUSWELL) a good buy?
On the numbers, ZYDUS WELLNESS LIMITED (ZYDUSWELL) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 76.3× earnings, ROE of 4.0%, a 56% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ZYDUSWELL overvalued or undervalued?
ZYDUSWELL trades at 76.3× earnings, expensive versus the ~22× long-run Nifty average.
What is the ZYDUSWELL share price target for 2031?
ZYDUSWELL's probability-weighted 2031 median target is ₹702, with an 80% range of ₹265-₹1,860 (10,000-path Monte-Carlo).
What is the probability ZYDUSWELL doubles in 5 years?
The modelled probability of ZYDUSWELL reaching ₹1,068 (2×) within 5 years is 30%.
What is the bull case for ZYDUSWELL?
ZYDUS WELLNESS LIMITED is part of the nifty200 universe with live, tracked fundamentals on Downstox.
What are the risks in ZYDUSWELL?
ZYDUSWELL's P/E of 76.7x is lower than 15% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. ZYDUSWELL's return on equity of 4.0% ranks in the 26th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.